CN
Clifford L Esq Neuman
Director

Clifford L Esq Neuman insider trades: Selectis Health (GBCS) stock buys and sales

Director, Selectis Health Last trade Jul 9, 2021 33 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2009
4
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Clifford reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 9, 2021GBCS↑ Buy$50K
Aug 15, 2011AHNR↓ Sell$40K
Apr 13, 2011AHNR↓ Sell$2K
Apr 11, 2011AHNR↓ Sell$14K
Apr 7, 2011AHNR↓ Sell$7K
Apr 4, 2011AHNR↓ Sell$443
Apr 1, 2011AHNR↓ Sell$2K
Mar 25, 2011AHNR↓ Sell$9K
Mar 21, 2011AHNR↓ Sell$782
Mar 11, 2011AHNR↓ Sell$6K
Dec 21, 2009GWBC↓ Sell$4K
Nov 27, 2009GWBC↓ Sell$300
Oct 26, 2009GWBC↓ Sell$250

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other GBCS insiders

Open-market trades in the last 12 months

About Clifford L Esq Neuman's insider trades

Clifford L Esq Neuman is a director at Selectis Health (GBCS). Since Oct 26, 2009, Clifford has reported 1 open-market purchase worth $50K and 12 sales worth $87K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (10 filings), gifts (6 filings), other transactions (4 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GBCS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.